Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion

Chest

Volumn 127, Issue 3, 2005, Pages 909-915

  Dresler, Carolyn M ^a   Olak, Jemi ^b   Herndon II, James E ^c   Richards, William G ^d   Scalzetti, Ernest ^e   Fleishman, Stewart B ^g   Kernstine, Kemp H ^h   Demmy, Todd ⁱ   Jablons, David M ^j   Kohman, Leslie ^f   Daniel, Thomas M ^k   Haasler, George B ^l   Sugarbaker, David J ^d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^c Cancer Center Biostatics   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Radiology Department   (United States)

^f SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^g ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ Roswell Cancer Institute   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^l MEDICAL COLLEGE OF WISCONSIN   (United States)

more..

Author keywords

Insufflation; Malignant pleural effusion; Slurry; Talc

Indexed keywords

TALC;

ADULT; AERATION; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEMOGRAPHY; DYSPNEA; FATIGUE; FEMALE; FEVER; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; OUTCOMES RESEARCH; PAIN; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY FAILURE; SAFETY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL; THORACOSCOPY; THORAX DRAINAGE; THORAX RADIOGRAPHY; TOXICITY; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PLEURODESIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INSUFFLATION; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; QUALITY OF LIFE; RECURRENCE; TALC; THORACOSCOPY; THORACOSTOMY;

EID: 20144377480     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.3.909     Document Type: Article

References (39)

1. Walker-Renard PB, Vaughan LM, Salin SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120:56-64
2. Fentiman IS, Rubens RD, Hayward JL. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol 1986; 22:1079-1081
3. Hamed H, Fentiman IS, Chaudary MA, et al. Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg 1989; 76:1266-1267
4. Hartman DL, Gaither JM, Kesler KA, et al. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993; 105: 743-747
5. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997; 112:430-434
6. Diacon AH, Wyser C, Bolliger CT, et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med 2000; 162:1445-1449
7. Bethune N. Pleural poudrage: a new technic for the deliberate production of pleural adhesions as a preliminary to lobectomy. J Thorac Surg 1935; 4:251-261
8. Hanrahan EM, Adams R, Klopstock R. The role of experimentally produced intrapleural adhesions in extrapleural pneumonolysis and in the prevention of surgical atelectasis in animals. J Thorac Surg 1941; 10:284-299
9. Chambers JS. Palliative treatment of neoplastic pleural effusion with intercostal intubation and talc instillation. West J Surg Obstet Gynecol 1958; 66:26-28
10. Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 1983; 85:523-526
11. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg 1999; 177:437-440
12. Fleishman SB, Dresler C, Herndon JE, et al. Quality of life (QOL) advantage of sclerosis for malignant pleural effusion (MPE) via talc thoracoscopy over chest tube infusion of talc slurry: a Cancer and Leukemia Group B study [abstract]. Proc Am Soc Clin Oncol 2002; 21:355a
13. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365-376
14. Common toxicity criteria, version 2.0. Bethesda, MD: National Cancer Institute, 1999
15. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106:1215-1222
16. Yim AP, Chan AT, Lee TVV, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996; 62:1655-1658
17. Cohen RG, Shely WW, Thompson SE, et al. Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg 1996; 62:1000-1002
18. Rodriguez Panadero F. Lung cancer and ipsilateral pleural effusion. Ann Oncol 1995; 6(suppl):S25-S27
19. Marom EM, Patz EF Jr, Erasmus JJ, et al. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999; 210:277-281
20. Jacobi CA, Wenger FA, Schmitz-Rixen T, et al. Talc pleurodesis in recurrent pleural effusions. Langenbecks Arch Surg 1998; 383:156-159
21. Adler RH, Sayek I. Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg 1976; 22:8-15
22. Schulze M, Boehle AS, Kurdow R, et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001; 71:1809-1812
23. Jones GR. Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis. Thorax 1969; 24:69-73
24. Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994; 106:342-346
25. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000; 117:73-78
26. Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions: a review of 360 cases. Chest 1996; 110:1387-1393
27. Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993; 106:689-695
28. Bouchama A, Chastre J, Gaudichet A, et al. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984; 86:795-797
29. de Campos JR, Vargas FS, de Campos Werebe E, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001; 119:801-806
30. Ferrer J, Montes JF, Villarino MA, et al. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002; 122:1018-1027
31. Ferrer J, Villarino MA, Tura JM, et al. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 2001; 119:1901-1905
32. Werebe EC, Pazetti R, Milanez de Campos JR, et al. Systemic distribution of talc after intrapleural administration in rats. Chest 1999; 115:190-193
33. Wegman DH, Peters JM, Boundy MG, et al. Evaluation of respiratory effects in miners and millers exposed to talc free of asbestos and silica. Br J Ind Med 1982; 39:233-238
34. Danby CA, Adebonojo SA, Moritz DM. Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and IV sedation. Chest 1998; 113:739-742
35. Sanchez-Armengol A, Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases. Chest 1993; 104:1482-1485
36. Rodriguez-Panadero F, Segado A, Martin Juan J, et al. Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med 1995; 151:785-790
37. Aelony Y, King RR, Boutin C. Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH. Chest 1998; 113:1007-1012
38. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure. Chest 2000; 117:87-95
39. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000; 117:79-86